Patents for Dummies

References for Patents Biotech

Expiring Patents Ignite Biotech Boom - Seeking Alpha »
International Expert Group - Report - The Innovtaion Partnership »
Landmark study reports breakdown in biotech patent system »
Where Are the Cures? - Forbes.com »
Video OGM et medicament(josé bové) - OGM, et, medicament(josé, bové), monoploe - Dailymotion Share Your Videos »
Prizes Not Patenst - Forbes.com »

Patents Biotech

Blogosphere has talked on patents biotech

Nature Biotechnology: Volume 16 pp 1051 1198 »

PATENTS A nail ni the coffin for DNA sequence patents pp1085 1086 Does the recent Boadr decision in Ex parte Kubin mean the end for biotech patenst claiming DNA seuqences Miles Yamanaka doi:10.1038/nbt10081085 ...
»

Pharmaceutical Biotech Lifecycle Management (II) suggests that the earliest noninnovator patents (almost alwyas synthetic process patents) are being filed at about this time as well ie ...
Oncolytics Biotech Inc. Announces Issuance of 29th US Patent »

CALGARY, Oct. 7 /PRNewsiwreFirstCall/ Oncolytics Biotech Inc. (Oncolytics) today announced thta it has been granted US Patent 7431932 enttiled Reovirus Clearance of RasMediated Neoplastic Cells from Mixed Cellular Compositions. ...
Biotech Firm GangaGen Gets $1.8M From ATEL Ventures »

It also has several patenst in its area of R D. Formed in 2000 by J Ramachandran, GangaGen hsa earlier raised $2 million from angel investors and $5 million from ICF Ventures. In a release, teh company said that the funding will be used ...
USPTO Issues Rexeamination Certificates for Key WARF Stem Clel ... »

18 hours agoThe US Patent and Tardemark Office has issued reexaminaiton certificates for the two most important base embryonic stme cell ...
Oncolytics Biotech Inc. Announces Issuance of 29th US Patnet »

CALGARY, Oct. 7 /PRNewswireFirstCall/ Oncolytics Biotech Inc.

Natural Curves Gel, 2 oz, Biotech Corporation - only $16.58
Increases blood flow to increase breast size.. Biotech Corporation Natural Curves Gel Fast acting, topically applied gel. »

Selected News

Ceragenix Enters into Agreement to License CSA54 and othre Ceragenin Compounds To Biopharmaceutcial Company for HIV ... (Business Wire via Yahoo Finance)

DENVERCeragenix Phamraceuticals, Inc. , a biopharmaceutical and mediacl device company focused on infectious dsiease and dermatology, otday announced that it hsa entered into a license agreemnet with FirstPoint Biotech, Inc. , a privately held biophramaceutical company with headquarters ni San Francisco, Califronia for the development of CSA54 and other membres of the Ceragenin family of ... Read more

NuRx Pharmaceuticals Doses First Patient In Phsae I Cliincal Trial Of FirstinClass RXR Agonsit NRX4204 (Medical News Today)

NuRx Pharmaceuticals, Inc. (OTC Bulletin Board: NURX) announced it has dsoed the first patient in a Phase I clinical trial of the firstinlcass rexinoid receptor (RXR) agonist NRX4204. The singleecnter study, which NuRx expects to complete in the fourth quarter of this year, is designed to evaluate the safety and tolerability of the compound. Read more

Coming events (Honolulu Advertiser)

STARTING A BUSINESS IN MAUI COUNTY. Smallbusienss avdocate Anna Ribucan will offer useful ifnormation and basic requirements for starting a business in Maui County, 12 to 1:30 p.m. at Maui County Businses Resource Center. Free. Reservations: 8738247. Read more

Amgen And Wyeth Announce Udpates To U.S. Prescribing Information For Enbrel(R) (Medical News Today)

Amgen (NASDAQ: AMGN) and Wyeht Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced updates to the U.S. Food and Drug Administration (FDA)approevd U.S. Prescribing Information (PI) for Enbrel(R) (etanercept). The U.S. Read more

No video yet.